Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhuvanesh Dave

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Genes & Nutrition|August 7, 2012
The soybean peptide lunasin promotes apoptosis of mammary epithelial cells via induction of tumor suppressor PTEN: similarities and distinct actions from soy isoflavone genisteinJohn Mark P Pabona, Bhuvanesh Dave, Ying Su, et al.
Plos One|August 11, 2012
Selective small molecule Stat3 inhibitor reduces breast cancer tumor-initiating cells and improves recurrence free survival in a human-xenograft modelBhuvanesh Dave, Melissa D Landis, David J Tweardy, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2011
Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinaseJoan T Garrett, María Graciela Olivares, Cammie Rinehart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Pharmacological Inhibition of NOS Activates ASK1/JNK Pathway Augmenting Docetaxel-Mediated Apoptosis in Triple-Negative Breast CancerDaniel Dávila-González, Dong Soon Choi, Roberto R Rosato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Loss of phosphatase and tensin homolog or phosphoinositol-3 kinase activation and response to trastuzumab or lapatinib in human epidermal growth factor receptor 2-overexpressing locally advanced breast cancersBhuvanesh Dave, Ilenia Migliaccio, M Carolina Gutierrez, et al.
Breast Cancer Research : BCR|April 8, 2015
Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancerSergio Granados-Principal, Yi Liu, Maria L Guevara, et al.
Journal of the National Cancer Institute|January 2, 2017
Role of RPL39 in Metaplastic Breast CancerBhuvanesh Dave, Daniel D Gonzalez, Zhi-Bin Liu, et al.
Stem Cells (Dayton, Ohio)|May 10, 2014
Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1Dong Soon Choi, Elvin Blanco, Yoo-Shin Kim, et al.
Breast Cancer Research and Treatment|August 8, 2019
Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastasesZhe-Bin Liu, Nader E Ezzedine, Agda K Eterovic, et al.
Cancer Research|July 23, 2009
Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathwayJudy S Crabtree, Scott A Jelinsky, Heather A Harris, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Genes & Nutrition|August 7, 2012
The soybean peptide lunasin promotes apoptosis of mammary epithelial cells via induction of tumor suppressor PTEN: similarities and distinct actions from soy isoflavone genisteinJohn Mark P Pabona, Bhuvanesh Dave, Ying Su, et al.
Plos One|August 11, 2012
Selective small molecule Stat3 inhibitor reduces breast cancer tumor-initiating cells and improves recurrence free survival in a human-xenograft modelBhuvanesh Dave, Melissa D Landis, David J Tweardy, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2011
Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinaseJoan T Garrett, María Graciela Olivares, Cammie Rinehart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Pharmacological Inhibition of NOS Activates ASK1/JNK Pathway Augmenting Docetaxel-Mediated Apoptosis in Triple-Negative Breast CancerDaniel Dávila-González, Dong Soon Choi, Roberto R Rosato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Loss of phosphatase and tensin homolog or phosphoinositol-3 kinase activation and response to trastuzumab or lapatinib in human epidermal growth factor receptor 2-overexpressing locally advanced breast cancersBhuvanesh Dave, Ilenia Migliaccio, M Carolina Gutierrez, et al.
Breast Cancer Research : BCR|April 8, 2015
Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancerSergio Granados-Principal, Yi Liu, Maria L Guevara, et al.
Journal of the National Cancer Institute|January 2, 2017
Role of RPL39 in Metaplastic Breast CancerBhuvanesh Dave, Daniel D Gonzalez, Zhi-Bin Liu, et al.
Stem Cells (Dayton, Ohio)|May 10, 2014
Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1Dong Soon Choi, Elvin Blanco, Yoo-Shin Kim, et al.
Breast Cancer Research and Treatment|August 8, 2019
Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastasesZhe-Bin Liu, Nader E Ezzedine, Agda K Eterovic, et al.
Cancer Research|July 23, 2009
Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathwayJudy S Crabtree, Scott A Jelinsky, Heather A Harris, et al.
Pageof 4